Plunging investments in life science startups threaten our medical future
Editor’s note: Congressional briefings are set for Friday at which the National Venture Capital Association and the Medical Innovation and Competitiveness Coalition will discuss their third “Patient Capital: Confronting the Crisis and Achieving the Promise of Venture-Backed Medical Innovation” report – the first since 2007 – that discusses what they see as the alarming state of investment in life science and medical device companies due to high costs, regulatory hurdles and other causes. Since North Carolina has the third largest life science industrial cluster in the U.S., WRALTechWire is publishing the executive summary of the report as written by Michael...
Read More
